W
WAVEMAN · COMPANY
WGS · Genedx Holdings Corp.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

WGS

GeneDx Holdings Corp.
HEALTHCARE SERVICES · SERVICES-HEALTH SERVICES · CIK 0001818331
CLUSTER · 3 INSIDERSFORM 144 · 2☆ WATCH
INSIDER NET · 180D
$86.1M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
3
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
145
13F, latest reported quarter
REVENUE GROWTH
+40.0%
XBRL, annual
NET MARGIN
-4.9%
CONVERSIONS · 180D
22
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$86.1M over 180 days
-$1.2M over 90 days · +$93.1M of it by a 10%+ holder
more than 98% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
145 funds added or opened last quarter
more than 54% of Healthcare Services
REVENUE
+40.0% year over year
more than 87% of Healthcare Services
MARGIN
-4.9% net margin
below 59% of Healthcare Services
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
3 insiders bought a net $86.1M, but 2 Form 144 notices ($1.7M) are queued to sell.
145 funds added or opened positions in the latest 13F quarter, of 236 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -32.3%
-32.3%12M
-73%-38%-4%+31%2025-092025-102025-122026-032026-052026-072026-09 2026-05-11 · Meister Keith A. bought $10.0M2026-05-11 · Meister Keith A. bought $9.6M2026-06-04 · Casdin Eli bought $8.5M2026-05-19 · Casdin Partners Master Fund, L.P. bought $7.9M2026-05-18 · Casdin Partners Master Fund, L.P. bought $7.4M2026-05-20 · Casdin Partners Master Fund, L.P. bought $6.1M2026-03-05 · Meister Keith A. bought $5.0M2026-05-07 · Meister Keith A. bought $4.6M2026-05-07 · Meister Keith A. bought $4.5M2026-05-07 · Meister Keith A. bought $4.5M2026-03-05 · Meister Keith A. bought $3.8M2026-05-07 · Meister Keith A. bought $3.7M2026-05-13 · Meister Keith A. bought $3.7M2026-05-14 · Meister Keith A. bought $3.4M2026-05-08 · Meister Keith A. bought $3.2M2026-05-08 · Meister Keith A. bought $3.0M2026-05-13 · Meister Keith A. bought $2.8M2026-06-05 · Casdin Eli bought $2.6M2026-03-05 · Meister Keith A. bought $2.4M2026-05-07 · Meister Keith A. bought $2.3M2026-05-14 · Meister Keith A. bought $2.1M2025-11-24 · RUCH JOSHUA sold $1.8M2025-11-24 · RUCH JOSHUA sold $1.4M2026-03-03 · Meister Keith A. bought $1.4M2025-09-16 · Stueland Katherine sold $1.3M2026-05-15 · Meister Keith A. bought $1.0M2025-11-24 · RUCH JOSHUA sold $1.0M2026-03-26 · Stueland Katherine sold $848.7K2026-03-04 · Stueland Katherine sold $822.7K2026-03-26 · Stueland Katherine sold $810.8K2026-05-15 · Meister Keith A. bought $751.4K2026-03-04 · Stueland Katherine sold $723.8K2026-03-16 · Stueland Katherine sold $711.1K2026-03-26 · Stueland Katherine sold $644.5K2026-03-03 · Meister Keith A. bought $603.2K2026-05-08 · Meister Keith A. bought $598.3K2025-12-09 · Stueland Katherine sold $579.6K2025-09-30 · Stueland Katherine sold $560.4K2026-03-16 · Stueland Katherine sold $548.0K2026-05-07 · Meister Keith A. bought $537.2K2025-09-30 · Stueland Katherine sold $480.2K2025-09-09 · Stueland Katherine sold $466.0K2026-09-01 · Kevin Feeley filed to sell $458.5K2026-09-01 · Katherine Stueland filed to sell $1.2M
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
3 insiders reported buying shares.
The record shows a net $86.1M bought by insiders over 180 days, 145 funds added last quarter, $1.7M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSPRVATDOCAVAHGHADUSSERABDSXENSG
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, GeneDx Holdings Corp. insiders bought a net $86.1M of stock across 399 Form 4 purchases and sales, with 3 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Feeley Kevin
CHIEF FINANCIAL OFFICER
SELL
2026-09-01
372.0
$31.2K
Feeley Kevin
CHIEF FINANCIAL OFFICER
SELL
2026-06-16
2,106.0
$128.1K
Feeley Kevin
CHIEF FINANCIAL OFFICER
SELL
2026-06-16
863.0
$53.1K
Feeley Kevin
CHIEF FINANCIAL OFFICER
SELL
2026-06-16
760.0
$45.4K
Stueland Katherine
CHIEF EXECUTIVE OFFICER
SELL
2026-06-16
5,932.0
$360.8K
399 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 394 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Corvex Management LP
4,784,570.0 sh
$328.5M
Casdin Capital, LLC
3,707,164.0 sh
$254.5M
BlackRock, Inc.
1,706,239.0 sh
$117.1M
GOLDMAN SACHS GROUP INC
1,669,441.0 sh
$114.6M
ARK Investment Management LLC
1,610,189.0 sh
$110.5M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Kevin Feeley
FILED 2026-09-01
$458.5K
Katherine Stueland
FILED 2026-09-01
$1.2M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Eventide Exponential Technologies Fund
$2.8M POSITION · AS OF 2026-03-31
3.7%
Harbor Health Care ETF
$584.2K POSITION · AS OF 2026-04-30
2.1%
ARK Genomic Revolution ETF
$25.2M POSITION · AS OF 2026-04-30
2.0%
Alger Small Cap Growth Portfolio
$2.3M POSITION · AS OF 2026-03-31
1.7%
Global X Genomics & Biotechnology ETF
$898.3K POSITION · AS OF 2026-02-28
1.7%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$1.3M POSITION · AS OF 2026-03-31
1.5%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Katherine Stueland
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$13.5M
$43.4M
$4.1M
+1394%
+39%
2024
$4.4M
$51.5M
$895.5K
+783%
+4%
2023
$3.5M
$545.9K
$1.2M
-68%
+5%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$427.5M$305.4M$202.6M$234.7M
GROSS PROFIT$298.2M$194.4M$90.0M$-26.8M
OPERATING INCOME$-13.1M$-23.2M$-180.6M$-667.7M
NET INCOME$-21.0M$-52.3M$-175.8M$-549.0M
EPS (DILUTED)-0.73-1.94-7.23-53.63
OPERATING CASH FLOW$33.3M$-28.5M$-180.1M$-319.2M
CASH$105.0M$85.2M$99.7M$123.9M
LONG-TERM DEBT$48.2M$51.9M$52.7M$6.2M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →